P
ALO ALTO, Calif.--Incyte Pharmaceuticals last month filed a patent infringement lawsuit against Gene Logic, alleging that a process used by Gene Logic for amplifying complementary DNA infringes US patents 5,716,785 and 5,891,636. Incyte also claimed that Gene Logic has infringed patent 4,981,783 in its use of cloned gene sequences as probes for expression analysis.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.